Matthew Peck

Matthew Peck is the Co-Founder of DaCapo Brainscience, a healthcare startup that focuses on developing therapies for neurodegenerative diseases. Prior to this role, Matthew was a Partner at Caxton Associates, where Matthew managed a portfolio of nearly $1 billion across various investment areas. Matthew also worked as a Portfolio Manager at DiMaio Ahmad Capital and as a Director at Salomon Brothers Inc, where Matthew earned multiple accolades for their work in credit analysis and emerging markets. Matthew holds a Bachelor of Arts in Economics & Government from Dartmouth College and graduated from Belmont Hill School.